Inflammation promotes endothelial dysfunction, but the underlying mechanisms remain poorly defined in vivo. Using translational vascular function testing in
myocardial infarction patients, a situation where
inflammation is prevalent, and knock-out (KO) mouse models we demonstrate a role for
mitogen-activated-protein-kinases (MAPKs) in endothelial dysfunction.
Myocardial infarction significantly lowers
mitogen and stress
kinase 1/2 (MSK1/2) expression in peripheral blood mononuclear cells and diminished endothelial function. To further understand the role of MSK1/2 in vascular function we developed in vivo animal models to assess vascular responses to vasoactive drugs using
laser Doppler imaging. Genetic deficiency of MSK1/2 in mice increased plasma levels of pro-inflammatory
cytokines and promoted endothelial dysfunction, through attenuated production of
nitric oxide (NO), which were further exacerbated by
cholesterol feeding. MSK1/2 are activated by
toll-like receptors through MyD88. MyD88 KO mice showed preserved endothelial function and reduced plasma
cytokine expression, despite significant
hypercholesterolemia. MSK1/2
kinases interact with MAPK-activated
proteins 2/3 (MAPKAP2/3), which limit
cytokine synthesis.
Cholesterol-fed MAPKAP2/3 KO mice showed reduced plasma
cytokine expression and preservation of endothelial function. MSK1/2 plays a significant role in the development of endothelial dysfunction and may provide a novel target for intervention to reduce vascular
inflammation. Activation of MSK1/2 could reduce pro-inflammatory responses and preserve endothelial
vasodilator function before development of significant
vascular disease.